Ensaculin Hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEnsaculin Hydrochloride
Drug Alias Name恩沙库林盐酸盐ensaculinumensaculineensaculinaAnseculin Hydrochloride +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr. Willmar Schwabe Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchwabe
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipedia